Ulrik Fahnøe

9PUBLICATIONS
35CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 25, 2024
Effect of direct-acting antivirals on the titers of human pegivirus 1 during treatment of chronic hepatitis C patients.

Ulrik Fahnøe, Lone Wulff Madsen, Peer Brehm Christensen

|Mar 31, 2023
Characterization of multi-DAA resistance using a novel hepatitis C virus genotype 3a infectious culture system.

Carlota Fernandez-Antunez, Kuan Wang, Ulrik Fahnøe

|Dec 21, 2022
Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system.

Yuyong Zhou, Karen Anbro Gammeltoft, Line Abildgaard Ryberg

|Aug 02, 2022
Inactivated genotype 1a, 2a and 3a HCV vaccine candidates induced broadly neutralising antibodies in mice.

Garazi Pena Alzua, Anne Finne Pihl, Anna Offersgaard

|May 31, 2022
A Distinct Dexamethasone-Dependent Gene Expression Profile in the Lungs of COVID-19 Patients.

Ulrik Fahnøe, Andreas Ronit, Ronan M G Berg

|Apr 09, 2021
HCV genome-wide analysis for development of efficient culture systems and unravelling of antiviral resistance in genotype 4.

Long V Pham, Martin Schou Pedersen, Ulrik Fahnøe

Pageof 2

Frequent Collaborators

8 joint publications

Jens Bukh

4 joint publications

Judith Margarete Gottwein

3 joint publications

Troels K H Scheel

2 joint publications

Santseharay Ramirez